Ogilvy CommonHealth names Samantha Dolin creative chief

Ogilvy CommonHealth names Samantha Dolin creative chief

Dolin is overseeing offices in New York, New Jersey, Connecticut, and Canada.

Five things for pharma marketers to know: Monday, July 16, 2018

Five things for pharma marketers to know: Monday, July 16, 2018

MM&M Awards shortlist revealed; FDA approves first smallpox treatment; Another way Amazon could drive down healthcare costs.

The 2018 MM&M Awards: The Shortlist

The 2018 MM&M Awards: The Shortlist

Find out who made award-winning work this year.

Rockpointe launches medical education program on Amazon's Alexa

Rockpointe launches medical education program on Amazon's Alexa

Alexa could make it easier for doctors to squeeze CME programs into their busy schedules.

MedStar Health selects Doner as AOR

MedStar Health selects Doner as AOR

Doner will lead a branding effort for the health system that will roll out in 2019.

Pfizer reorg came on heels of its walk-back on price hikes

Pfizer reorg came on heels of its walk-back on price hikes

Wednesday's reorg was designed to position the company for growth in the face of the imminent patent cliff for megablockbuster Lyrica.

McCann Health terminates global CCO following employee complaint

McCann Health terminates global CCO following employee complaint

The agency said Jeremy Perrott violated the agency's code of conduct.

Five things for pharma marketers to know: Thursday, July 12, 2018

Five things for pharma marketers to know: Thursday, July 12, 2018

New report reveals large amount of opioids shipped to Missouri; Humana partners with Walgreens; Wyden requests details on Trump-Pfizer agreement

MediaMonks: The lowdown on the company that topped Sorrell's shopping list

MediaMonks: The lowdown on the company that topped Sorrell's shopping list

If you were unfamiliar with MediaMonks and want to know more about the company that Martin Sorrell has made his first capture, read on.

Ogilvy Worldwide creative chief fired after internal investigation

Ogilvy Worldwide creative chief fired after internal investigation

Tham Khai Meng has been with Ogilvy since 1999.

John Reid steps into SVP, executive creative role at Razorfish Health

John Reid steps into SVP, executive creative role at Razorfish Health

He's a veteran of Deep Focus, Wunderman, and ATTIK.

FDA wants clearer indications, usage language on product labels

FDA wants clearer indications, usage language on product labels

The government agency released its latest guidance this week.

Twitter purge of locked accounts welcomed by Unilever's Keith Weed

Twitter purge of locked accounts welcomed by Unilever's Keith Weed

Some Twitter accounts could lose millions of followers when the social platform purges large numbers of "locked" accounts this week.

Five things for pharma marketers to know: Wednesday, July 11, 2018

Five things for pharma marketers to know: Wednesday, July 11, 2018

Pfizer announces restructuring hours after about face on price hikes; Feds to slash funding for ACA "navigators"; Study finds rural states lag in combating heart disease.

Sorrell interview on MediaMonks' deal: 'You can celebrate for a nano-second'

Sorrell interview on MediaMonks' deal: 'You can celebrate for a nano-second'

In an interview with Campaign, Sir Martin Sorrell insisted his new company, S4 Capital, is listening to clients because they are "questioning" how agencies are delivering work.

Sorrell reveals 'very different approach' with $352.3m MediaMonks deal

Sorrell reveals 'very different approach' with $352.3m MediaMonks deal

Sir Martin Sorrell's S4 Capital has agreed to buy Dutch content business MediaMonks in a deal that is strikingly different from how he structured acquisitions at WPP.

Purdue's sales force targeted high prescribers with a 'false narrative,' unsealed lawsuit says

Purdue's sales force targeted high prescribers with a 'false narrative,' unsealed lawsuit says

Directing its reps to call on GPs with little to no opioid experience, Purdue introduced aggressive promotional tactics into the prescription opioid marketing playbook.

Did the market overreact to Biogen's Alzheimer's data?

Did the market overreact to Biogen's Alzheimer's data?

Biogen's recently soaring stock price can be attributed to investor optimism in one of the most stubborn areas of drug development.

Five things for pharma marketers to know: Tuesday, July 10, 2018

Five things for pharma marketers to know: Tuesday, July 10, 2018

CMS ends plan to make Novartis cancer treatment cheaper; Trump calls out Pfizer on Twitter for price hikes; News organizations sue to get federal opioid data.

Five Agency 100 things for pharma marketers to know: Monday, July 9, 2018

Five Agency 100 things for pharma marketers to know: Monday, July 9, 2018

The most comprehensive look at the pharma and healthcare agency world from MM&M.

2018 Agency 100 overview: firms adapt to stay ahead of nontraditional players

2018 Agency 100 overview: firms adapt to stay ahead of nontraditional players

There was a resetting of healthcare agency priorities in 2017, from income mix to what's keeping them up at night. But revenue continues its steady uptick as firms attempt to stay a step ahead of nontraditional players.

3 questions for holding company CEOs, with further insights from consultancies

3 questions for holding company CEOs, with further insights from consultancies

CEOs of the healthcare industry's largest holding companies discuss the future of the business and the importance of data privacy.

2018 MM&M Agency 100: Welcome to the new agency world

2018 MM&M Agency 100: Welcome to the new agency world

Everything you need to know about the agency world in medical marketing and communications - including revenue performance and profiles for the top 100 agencies - as well as the trends shaping the industry in general.

Ashfield continues acquisition binge by snapping up Create NYC, SmartAnalyst

Ashfield continues acquisition binge by snapping up Create NYC, SmartAnalyst

The deals follow last year's additions of Cambridge BioMarketing and MicroMass Communications.

Five things for pharma marketers to know: Friday, July 6, 2018

Five things for pharma marketers to know: Friday, July 6, 2018

Positive Alzheimer's trial sends Biogen shares surging; A year after crisis, analysts come around to AstraZeneca stock; Ironwood cuts 40 jobs ahead of split.

Five things for pharma marketers to know: Thursday, July 5, 2018

Five things for pharma marketers to know: Thursday, July 5, 2018

Amazon integration with PillPack could happen quickly; White House names DEA chief; Purdue stops marketing opioids in Canada.

GW Pharma's Justin Gover on marketing the first cannabis-based drug

GW Pharma's Justin Gover on marketing the first cannabis-based drug

11 questions for the GW CEO on the watershed moment.

WPP threatens to pull Sorrell's bonus if he wins MediaMonks bid

WPP threatens to pull Sorrell's bonus if he wins MediaMonks bid

WPP is also bidding for Dutch agency MediaMonks, pitting the group against its former chief executive, Martin Sorrell.

Ariel Buda-Levin named EVP, MD of clinical trial recruitment firm FCBVIO

Ariel Buda-Levin named EVP, MD of clinical trial recruitment firm FCBVIO

She is taking on the role alongside her role leading FCB Health medical communications subsidiary ProHealth.

Five things for pharma marketers to know: Tuesday, July 3, 2018

Five things for pharma marketers to know: Tuesday, July 3, 2018

UDG Healthcare makes two acquisitions; Lundbeck names Dunsire CEO; Accuracy of DTC genetic tests questioned.

IPG acquires Acxiom for $2.3 billion

IPG acquires Acxiom for $2.3 billion

Data marketing firm will become part of IPG Mediabrands portfolio.

FDA reprimands Pfizer for leaving risk information out of Estring video

FDA reprimands Pfizer for leaving risk information out of Estring video

The Office of Prescription Drug Promotion has sent its second warning letter of the year.

Epilepsy group has advice for Pixar following its photosensitivity faux paus

Epilepsy group has advice for Pixar following its photosensitivity faux paus

Fans hailed Disney's response following a strobe-light slip-up in the film Incredibles 2, but a patient group says it must go a step further as it seeks to recover from the blunder.

Five things for pharma marketers to know: Monday, July 2, 2018

Five things for pharma marketers to know: Monday, July 2, 2018

U.S. hospitals face staple drug shortage; Pfizer hikes price of 100 products; Federal judge blocks Kentucky work-requirement-for-Medicaid plan.

How the Amazon-PillPack deal could benefit pharma and win over patients

How the Amazon-PillPack deal could benefit pharma and win over patients

A survey from DRG Digital measured patient and doctor support for Amazon becoming an online pharmacy.

Five things for pharma marketers to know: Friday, June 29, 2018

Five things for pharma marketers to know: Friday, June 29, 2018

Fosamax appeal goes to Supreme Court; Gottlieb weighs in on Amazon-PillPack deal; Senator demands PhRMA, BIO address sexual harassment.

Allergan gets candid about birth control in Lo Loestrin Fe campaign

Allergan gets candid about birth control in Lo Loestrin Fe campaign

The campaign is appearing in millennial- and women-focused outlets such as Refinery29, Instagram, Bravo!, HGTV, and Cosmopolitan.

Five things for pharma marketers to know: Thursday, June 28, 2018

Five things for pharma marketers to know: Thursday, June 28, 2018

Amazon to acquire PillPack; Babylon Health says its AI diagnoses better than humans; Lilly's arthritis drug sees positive results.

The caregiver's journey is a highly personal one. A study examined their role in treatment decisions

The caregiver's journey is a highly personal one. A study examined their role in treatment decisions

Caregivers are intimately involved in patient health, and that includes deciding on treatments, a new study suggests.

Three quarters of Americans support listing drug prices in DTC ads: Kaiser survey

Three quarters of Americans support listing drug prices in DTC ads: Kaiser survey

Across the political spectrum, most Americans favor President Donald Trump's proposal to show drug prices in advertisements.

Bayer dropped pitchwoman for bobblehead to save money: lawsuit

Bayer dropped pitchwoman for bobblehead to save money: lawsuit

The lawyer for former spokesperson Phoebe Jonas said Bayer created "a big headache for everyone."

Cancer organizations get marketing tips from consumer brands to improve patient education

Cancer organizations get marketing tips from consumer brands to improve patient education

The partnerships came about after the Multiple Myeloma Research Foundation and Kantar Health conducted a study on cancer patients' knowledge gaps.

Five things for pharma marketers to know: Wednesday, June 27, 2018

Five things for pharma marketers to know: Wednesday, June 27, 2018

FDA gives priority review to new type of flu treatment; Lynparza shows positive trial data; Nurse practitioner lobby launches national campaign.

Sorrell reveals WPP regrets in not moving faster with 'horizontality'

Sorrell reveals WPP regrets in not moving faster with 'horizontality'

Sir Martin Sorrell regrets not simplifying WPP faster in terms of client-focused work, more country management and making sure this it is underpinned by digital.

Aline Santos: there is lot of diversity talk at Cannes but not much action

Aline Santos: there is lot of diversity talk at Cannes but not much action

Unilever's diversity and inclusion chief Aline Santos has criticized the industry for a lack of action but welcomed the accountability that has come with a spotlight being shone on the issues.

Inside pharma's trust problem

Inside pharma's trust problem

Public trust in the pharma industry has taken a dip, according to recent data. Do actual patients agree?

Intouch Solutions reorganizes into six-firm network

Intouch Solutions reorganizes into six-firm network

Wendy Blackburn, EVP of marketing and communications, described the new structure as "a natural evolution of everything we've been doing."

Five things for pharma marketers to know: Monday, June 25, 2018

Five things for pharma marketers to know: Monday, June 25, 2018

How Atul Gawande caught Warren Buffett's eye; Positive news for Roche's Tecentriq in trial; New York State officials argue Orkambi not worth the cost.

Close, but not quite the Grand Prix

Close, but not quite the Grand Prix

Cannes judges on why one campaign just missed the top Pharma Lions prize.

Unilever brings holding group creative teams together for new agency model trial

Unilever brings holding group creative teams together for new agency model trial

Unilever is trialing a new agency model which will see creative agency talent within a holding group integrated into a single team.

Five things for pharma marketers to know: Friday, June 22, 2018

Five things for pharma marketers to know: Friday, June 22, 2018

Opioid supply levels drop; Azar criticized for attending college reunion during border crisis; CVS CEO confident about Aetna deal.

Biogen, MyMSTeam social network launch patient education resource

Biogen, MyMSTeam social network launch patient education resource

The goal of the product is to educate MS patients about the effect the disease has on cognition.

Five things for pharma marketers to know: Thursday, June 21, 2018

Five things for pharma marketers to know: Thursday, June 21, 2018

GoodRx in sales talks; Heron receives breakthrough therapy designation for pain treatment; Novo's diabetes pill proves effective in clinical trials.

Who's your prescriber now? Demand for NPs and PAs is booming, according to report

Who's your prescriber now? Demand for NPs and PAs is booming, according to report

Recent healthcare trends, including a physician shortage and the rise of value-based care centers, have put NPs and PAs on the fast track to recruiter popularity. Marketers, take note.

Five things for pharma marketers to know: Wednesday, June 20, 2018

Five things for pharma marketers to know: Wednesday, June 20, 2018

Dr. Atul Gawande named CEO of Amazon, J.P. Morgan, Berkshire Hathaway healthcare venture; Facebook tries to curb illegal opioid sales; More sales layoffs at Purdue Pharma.

Global ad investment to grow 4.5% in 2018

Global ad investment to grow 4.5% in 2018

New advertising will account for a $24 billion investment this year.

What CMOs are thinking in Cannes

What CMOs are thinking in Cannes

As the Cannes CMO Growth Council meets, marketers weigh in on what they're looking to gain from the Festival and this year's changes.

Kim Kardashian deletes Instagram post promoting morning sickness drug

Kim Kardashian deletes Instagram post promoting morning sickness drug

Kardashian's previous posts for Duchesnay's morning sickness treatments were slammed by the FDA for not including side effects or risk information.

Five things for pharma marketers to know: Tuesday, June 19, 2018

Five things for pharma marketers to know: Tuesday, June 19, 2018

White House to roll out Affordable Care Act rule change; CVS Health teams up with Postal Service; Roche to buy rest of Foundation Medicine.

FBI probes media trading practices in the US

FBI probes media trading practices in the US

The Federal Bureau of Investigation is looking into media trading and transparency in the US advertising market.

Montefiore's Corazon - Give Your Heart campaign wins health & wellness Grand Prix

Montefiore's Corazon - Give Your Heart campaign wins health & wellness Grand Prix

Judges awarded the category's top prize to New York's John X. Hannes on behalf of Montefiore. They also handed out eight Gold Lions.

No pharma Grand Prix awarded for second straight year

No pharma Grand Prix awarded for second straight year

Since the inception of the award in 2014, the pharma Grand Prix has only been awarded twice.

Lions Health: 2018 pharma winners

Lions Health: 2018 pharma winners

Here are the Lions Health winners in the pharma category.

Lions Health: 2018 health and wellness winners

Lions Health: 2018 health and wellness winners

Here are the Lions Health winners in the health and wellness category.

WPP's Read: We're focusing on collaboration, rather than 'collapsing' agency brands and restructuring

WPP's Read: We're focusing on collaboration, rather than 'collapsing' agency brands and restructuring

Mark Read has warned against "collapsing" too many WPP agency brands and said driving greater collaboration is more important than a "major restructuring".

'Creativity is not on pause because one group is not in Cannes'

'Creativity is not on pause because one group is not in Cannes'

This year's Cannes Lions Festival will be different to any that preceded it - but then, it was always thus.

Five things for pharma marketers to know: Monday, June 18, 2018

Five things for pharma marketers to know: Monday, June 18, 2018

Quest Analytics buys BetterDoctor; Analyst Eric Schmidt to join Allogene Therapeutics; Two-thirds of Americans "very concerned" about cost of health insurance.

Confusion expected in wake of 'Right to Try' bill's signing

Confusion expected in wake of 'Right to Try' bill's signing

It's still entirely up to drugmakers whether they want to make their products available on an experimental basis. Patients may not see it that way.

U.S. beefs up presence on Cannes Pharma Lions shortlist

U.S. beefs up presence on Cannes Pharma Lions shortlist

FCB Health features heavily in a rising percentage of U.S. campaigns that made it to the Pharma Lions shortlist - the company's Rich Levy is jury president this year.

How Digitas Health's Collette Douaihy does Cannes

How Digitas Health's Collette Douaihy does Cannes

Collete Douaihy, Digitas Health's executive vice president, executive creative director shares advice for navigating Cannes, her opinion on the new schedule, and how she's handling judging.

Five things for pharma marketers to know: Friday, June 16, 2018

Five things for pharma marketers to know: Friday, June 16, 2018

Eli Lilly CEO says changes needed in drug pricing system; Kentucky sues Walgreens over opioid epidemic; Teva faces migraine drug setback.

Cannes awards entries fall by a fifth in watershed year

Cannes awards entries fall by a fifth in watershed year

The number of entries to Cannes Lions has dropped by 21.4% from last year, which organisers ascribed partly to Publicis Groupe's temporary withdrawal and partly to their decision to restructure the awards programme.

Outcome Health turns to Matt McNally as CEO

Outcome Health turns to Matt McNally as CEO

Rishi Shah stepped down from the chief executive position five months ago amid fraud allegations.

FDA guidelines for payer, off-label communications: OK as long as 'truthful'

FDA guidelines for payer, off-label communications: OK as long as 'truthful'

Two FDA guidance documents aim to help pharma companies show the value of their drugs to payers beyond what's included in FDA labeling.

Five things for pharma marketers to know: Thursday, June 14, 2018

Five things for pharma marketers to know: Thursday, June 14, 2018

BIO afterparty again sparks controversy; GSK meets goal for two-drug HIV treatment; Mylan receives complete response letter for Advair generic.

'The elephant in the room': Absent Sorrell inspires anger and affection at WPP

'The elephant in the room': Absent Sorrell inspires anger and affection at WPP

In the week that former WPP chief Sir Martin Sorrell faced claims of bullying behaviour and paying for a prostitute, the ad group will be breathing a sigh of relief after an AGM that avoided a showdown.

Ogilvy stresses post-restructuring flexibility in health work

Ogilvy stresses post-restructuring flexibility in health work

The WPP agency is hoping its reorganization results in more collaboration among health and wellness staffers.

Five things for pharma marketers to know: Wednesday, June 13, 2018

Five things for pharma marketers to know: Wednesday, June 13, 2018

Drugmakers not dropping prices on Trump timeline; Azar backs insurance for those with preexisting conditions; Stryker denies interest in Boston Scientific takeover.

Sorrell's $26.7 million pay-off triggers WPP shareholder rebellion

Sorrell's $26.7 million pay-off triggers WPP shareholder rebellion

WPP faced tough questions about Sir Martin Sorrell's exit at its annual general meeting, with more than a quarter of WPP shareholders voting against his entitlement to a possible $26.7 million pay-off.

GMHC takes Blood Equality push overseas

GMHC takes Blood Equality push overseas

For the first time, the nonprofit is trying to eliminate bans on gay and bisexual men donating blood in countries other than the U.S.

WPP's Read writes to staff about importance of 'respect' in wake of Sorrell press coverage

WPP's Read writes to staff about importance of 'respect' in wake of Sorrell press coverage

WPP joint COO Mark Read has emailed all staff at the group to tell them to expect respect from their colleagues and announce a group-wide code of conduct review.

Five things for pharma marketers to know: Tuesday, June 12, 2018

Five things for pharma marketers to know: Tuesday, June 12, 2018

FDA puts Sage depression treatment on accelerated timeline; AstraZeneca, Lilly cease Alzheimer's treatment trial; Stryker makes offer for Boston Scientific.

Sorrell in the headlines over 'sex, cash, and bullying' claims

Sorrell in the headlines over 'sex, cash, and bullying' claims

Martin Sorrell's reputation is under increasing fire from the press, with both the 'Financial Times' and the 'Daily Mail' using their front pages to air allegations about his conduct today.

Five things pharma marketers need to know: Monday, June 11, 2018

Five things pharma marketers need to know: Monday, June 11, 2018

Eckert returns to lead Sprout Pharmaceuticals; Sorrell denies prostitution allegation; AHIP warns about removing key Obamacare provisions.

Sorrell denies prostitute allegation

Sorrell denies prostitute allegation

WPP's unpublished investigation into its former chief executive Martin Sorrell's conduct examined whether he used company funds to pay a prostitute, according to reports.

How Sudler Australia's Cherie Davies does Cannes

How Sudler Australia's Cherie Davies does Cannes

The creative director of Sudler Australia shares her opinion on changes to Cannes' scheduling and how she's preparing for long days spent judging.

WPP faces protest over Sorrell pay-off but Quarta is set to stay as chairman

WPP faces protest over Sorrell pay-off but Quarta is set to stay as chairman

WPP investors are set to lodge a significant protest over Sir Martin Sorrell's pay-off but executive chairman Roberto Quarta is expected to survive.

Five things for pharma marketers to know: Friday, June 8, 2018

Five things for pharma marketers to know: Friday, June 8, 2018

Novo Nordisk considers cutting 3,000 jobs; Pharma companies pressured to move birth control over the counter; Gates Foundation launches a nonprofit biotech.

Former JWT chief Gustavo Martinez exits WPP two years after sexual harassment row

Former JWT chief Gustavo Martinez exits WPP two years after sexual harassment row

Former JWT global chief executive Gustavo Martinez has departed WPP in a sign that the ad group's new leadership wants to draw a line under his controversial tenure.

How women can empower themselves to close biopharma's gender pay gap

How women can empower themselves to close biopharma's gender pay gap

Women healthcare leaders discussed the gender pay gap and tools for women to advocate for themselves on stage at MM&M's Hall of Femme event Thursday.

'Keep knocking on the door': Executives urge women to trust their potential

'Keep knocking on the door': Executives urge women to trust their potential

Life and career lessons from Novartis' Vanessa Thirion-Cullity and other executives.

Read the June 2018 Digital Edition

Read the June 2018 Digital Edition

The State of Diversity in Healthcare Marketing: For years, pharma has talked about diversity and inclusion issues in its midst, with some pundits saying the industry was slow to embrace diversity and others claiming that it's ahead of the curve.

Five things for pharma marketers to know: Thursday, June 7, 2018

Five things for pharma marketers to know: Thursday, June 7, 2018

Bayer closes Monsanto deal after lengthy antitrust review; Bezos, Dimon, Buffett pick CEO to run healthcare venture; Novartis to avoid criminal actions over Cohen payments.

AARP, tech firms to test voice-based health tools among senior set

AARP, tech firms to test voice-based health tools among senior set

Pillo's voice-activated robot will be studied among those 50-plus with diabetes. The robot uses facial recognition and can respond HIPAA-compliantly to questions.

How Ogilvy's Andrew Schirmer does Cannes

How Ogilvy's Andrew Schirmer does Cannes

The CEO of Ogilvy CommonHealth North America shares advice for first-time attendees at Cannes.

Five things for pharma marketers to know: Wednesday, June 6, 2018

Five things for pharma marketers to know: Wednesday, June 6, 2018

Athenahealth CEO steps down; Former Celgene chief executive wins New Jersey Senate primary; Big Pharma not planning campaign against Trump drug pricing plan.

WPP investor pressure to sell Kantar could open door to Sorrell acquisition spree

WPP investor pressure to sell Kantar could open door to Sorrell acquisition spree

Investor pressure is likely to force WPP into selling Kantar, possibly along with other assets - which could open opportunities for Sir Martin Sorrell's new vehicle S4 Capital.

'Will Marcel replace creatives?': Sadoun faces deluge of questions from Publicis staff and clients

'Will Marcel replace creatives?': Sadoun faces deluge of questions from Publicis staff and clients

Just after the launch of Marcel, Publicis chief executive Arthur Sadoun was bombarded with questions from a packed room of clients, staff, and journalists.

AstraZeneca's Olivier Nataf on how his long tenure shapes his current role

AstraZeneca's Olivier Nataf on how his long tenure shapes his current role

AstraZeneca VP, head of U.S. oncology, Olivier Nataf details how being a company lifer impacted his career.